nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—Parkinson's disease—Diphenhydramine—atopic dermatitis	0.602	1	CpDpCtD
Bromocriptine—CYP3A4—Pimecrolimus—atopic dermatitis	0.0202	0.111	CbGbCtD
Bromocriptine—ABCB1—Tacrolimus—atopic dermatitis	0.02	0.11	CbGbCtD
Bromocriptine—CYP1A2—Diphenhydramine—atopic dermatitis	0.0167	0.0922	CbGbCtD
Bromocriptine—ABCB1—Loratadine—atopic dermatitis	0.0146	0.0806	CbGbCtD
Bromocriptine—ABCB1—Methylprednisolone—atopic dermatitis	0.0134	0.0738	CbGbCtD
Bromocriptine—CYP3A4—Tacrolimus—atopic dermatitis	0.012	0.066	CbGbCtD
Bromocriptine—CYP3A4—Loratadine—atopic dermatitis	0.00877	0.0483	CbGbCtD
Bromocriptine—ABCB1—Betamethasone—atopic dermatitis	0.00871	0.048	CbGbCtD
Bromocriptine—ABCB1—Prednisolone—atopic dermatitis	0.00859	0.0473	CbGbCtD
Bromocriptine—DRD5—eyelid—atopic dermatitis	0.00851	0.525	CbGeAlD
Bromocriptine—ABCB1—Hydrocortisone—atopic dermatitis	0.00814	0.0449	CbGbCtD
Bromocriptine—ABCB1—Prednisone—atopic dermatitis	0.00811	0.0447	CbGbCtD
Bromocriptine—CYP3A4—Methylprednisolone—atopic dermatitis	0.00802	0.0442	CbGbCtD
Bromocriptine—CYP3A4—Triamcinolone—atopic dermatitis	0.00608	0.0335	CbGbCtD
Bromocriptine—CYP3A4—Betamethasone—atopic dermatitis	0.00522	0.0287	CbGbCtD
Bromocriptine—CYP3A4—Prednisolone—atopic dermatitis	0.00515	0.0283	CbGbCtD
Bromocriptine—ABCB1—Dexamethasone—atopic dermatitis	0.00506	0.0279	CbGbCtD
Bromocriptine—CYP3A4—Hydrocortisone—atopic dermatitis	0.00488	0.0269	CbGbCtD
Bromocriptine—CYP3A4—Prednisone—atopic dermatitis	0.00486	0.0268	CbGbCtD
Bromocriptine—CYP3A4—Dexamethasone—atopic dermatitis	0.00303	0.0167	CbGbCtD
Bromocriptine—HTR7—neck—atopic dermatitis	0.000608	0.0375	CbGeAlD
Bromocriptine—DRD3—head—atopic dermatitis	0.000574	0.0354	CbGeAlD
Bromocriptine—HTR6—head—atopic dermatitis	0.000552	0.0341	CbGeAlD
Bromocriptine—DRD5—head—atopic dermatitis	0.000538	0.0332	CbGeAlD
Bromocriptine—HTR2B—skin of body—atopic dermatitis	0.00046	0.0284	CbGeAlD
Bromocriptine—ADRA1B—head—atopic dermatitis	0.000441	0.0272	CbGeAlD
Bromocriptine—ADRA1D—head—atopic dermatitis	0.000431	0.0266	CbGeAlD
Bromocriptine—DRD1—head—atopic dermatitis	0.000411	0.0254	CbGeAlD
Bromocriptine—HTR2A—neck—atopic dermatitis	0.000379	0.0234	CbGeAlD
Bromocriptine—HTR1B—head—atopic dermatitis	0.000333	0.0206	CbGeAlD
Bromocriptine—HTR1D—head—atopic dermatitis	0.000322	0.0199	CbGeAlD
Bromocriptine—HTR2C—head—atopic dermatitis	0.000319	0.0197	CbGeAlD
Bromocriptine—ADRB1—head—atopic dermatitis	0.000313	0.0193	CbGeAlD
Bromocriptine—HTR2B—head—atopic dermatitis	0.0003	0.0185	CbGeAlD
Bromocriptine—HTR1A—head—atopic dermatitis	0.000269	0.0166	CbGeAlD
Bromocriptine—HTR7—head—atopic dermatitis	0.000257	0.0159	CbGeAlD
Bromocriptine—ADRA1A—head—atopic dermatitis	0.000248	0.0153	CbGeAlD
Bromocriptine—DRD2—head—atopic dermatitis	0.000243	0.015	CbGeAlD
Bromocriptine—ADRA2C—head—atopic dermatitis	0.000236	0.0146	CbGeAlD
Bromocriptine—ADRA2A—head—atopic dermatitis	0.000188	0.0116	CbGeAlD
Bromocriptine—HTR2A—head—atopic dermatitis	0.00016	0.00989	CbGeAlD
Bromocriptine—Arrhythmia—Hydrocortisone—atopic dermatitis	0.000114	0.00083	CcSEcCtD
Bromocriptine—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000113	0.000827	CcSEcCtD
Bromocriptine—Eye disorder—Methylprednisolone—atopic dermatitis	0.000112	0.000816	CcSEcCtD
Bromocriptine—Mental disorder—Hydrocortisone—atopic dermatitis	0.000111	0.000814	CcSEcCtD
Bromocriptine—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000111	0.00081	CcSEcCtD
Bromocriptine—Bradycardia—Betamethasone—atopic dermatitis	0.000111	0.000808	CcSEcCtD
Bromocriptine—Bradycardia—Dexamethasone—atopic dermatitis	0.000111	0.000808	CcSEcCtD
Bromocriptine—Angiopathy—Methylprednisolone—atopic dermatitis	0.000108	0.000792	CcSEcCtD
Bromocriptine—Hallucination—Dexamethasone—atopic dermatitis	0.000108	0.00079	CcSEcCtD
Bromocriptine—Hallucination—Betamethasone—atopic dermatitis	0.000108	0.00079	CcSEcCtD
Bromocriptine—Nausea—Mometasone—atopic dermatitis	0.000108	0.00079	CcSEcCtD
Bromocriptine—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000108	0.000787	CcSEcCtD
Bromocriptine—Arrhythmia—Triamcinolone—atopic dermatitis	0.000107	0.000781	CcSEcCtD
Bromocriptine—Vision blurred—Prednisolone—atopic dermatitis	0.000107	0.00078	CcSEcCtD
Bromocriptine—Arrhythmia—Methylprednisolone—atopic dermatitis	0.000107	0.00078	CcSEcCtD
Bromocriptine—ABCB1—head—atopic dermatitis	0.000105	0.00648	CbGeAlD
Bromocriptine—Visual impairment—Dexamethasone—atopic dermatitis	0.000105	0.000765	CcSEcCtD
Bromocriptine—Visual impairment—Betamethasone—atopic dermatitis	0.000105	0.000765	CcSEcCtD
Bromocriptine—Mental disorder—Methylprednisolone—atopic dermatitis	0.000105	0.000765	CcSEcCtD
Bromocriptine—Asthenia—Tacrolimus—atopic dermatitis	0.000104	0.000759	CcSEcCtD
Bromocriptine—Acute coronary syndrome—Prednisone—atopic dermatitis	0.000104	0.000759	CcSEcCtD
Bromocriptine—Myocardial infarction—Prednisone—atopic dermatitis	0.000103	0.000755	CcSEcCtD
Bromocriptine—Dysgeusia—Triamcinolone—atopic dermatitis	0.000102	0.000746	CcSEcCtD
Bromocriptine—Vertigo—Prednisolone—atopic dermatitis	0.000102	0.000744	CcSEcCtD
Bromocriptine—Syncope—Prednisolone—atopic dermatitis	0.000102	0.000743	CcSEcCtD
Bromocriptine—Eye disorder—Dexamethasone—atopic dermatitis	0.000102	0.000742	CcSEcCtD
Bromocriptine—Eye disorder—Betamethasone—atopic dermatitis	0.000102	0.000742	CcSEcCtD
Bromocriptine—Loss of consciousness—Prednisolone—atopic dermatitis	9.96e-05	0.000728	CcSEcCtD
Bromocriptine—Vertigo—Hydrocortisone—atopic dermatitis	9.94e-05	0.000727	CcSEcCtD
Bromocriptine—Syncope—Hydrocortisone—atopic dermatitis	9.93e-05	0.000725	CcSEcCtD
Bromocriptine—Diarrhoea—Tacrolimus—atopic dermatitis	9.91e-05	0.000724	CcSEcCtD
Bromocriptine—Angiopathy—Betamethasone—atopic dermatitis	9.86e-05	0.00072	CcSEcCtD
Bromocriptine—Angiopathy—Dexamethasone—atopic dermatitis	9.86e-05	0.00072	CcSEcCtD
Bromocriptine—Convulsion—Prednisolone—atopic dermatitis	9.82e-05	0.000717	CcSEcCtD
Bromocriptine—Hypertension—Prednisolone—atopic dermatitis	9.78e-05	0.000715	CcSEcCtD
Bromocriptine—Loss of consciousness—Hydrocortisone—atopic dermatitis	9.73e-05	0.000711	CcSEcCtD
Bromocriptine—Arrhythmia—Betamethasone—atopic dermatitis	9.7e-05	0.000709	CcSEcCtD
Bromocriptine—Arrhythmia—Dexamethasone—atopic dermatitis	9.7e-05	0.000709	CcSEcCtD
Bromocriptine—Bradycardia—Prednisone—atopic dermatitis	9.63e-05	0.000704	CcSEcCtD
Bromocriptine—Alopecia—Dexamethasone—atopic dermatitis	9.6e-05	0.000701	CcSEcCtD
Bromocriptine—Alopecia—Betamethasone—atopic dermatitis	9.6e-05	0.000701	CcSEcCtD
Bromocriptine—Convulsion—Hydrocortisone—atopic dermatitis	9.59e-05	0.000701	CcSEcCtD
Bromocriptine—Dizziness—Tacrolimus—atopic dermatitis	9.57e-05	0.0007	CcSEcCtD
Bromocriptine—Hypertension—Hydrocortisone—atopic dermatitis	9.56e-05	0.000698	CcSEcCtD
Bromocriptine—Hallucination—Prednisone—atopic dermatitis	9.41e-05	0.000688	CcSEcCtD
Bromocriptine—Anxiety—Hydrocortisone—atopic dermatitis	9.39e-05	0.000686	CcSEcCtD
Bromocriptine—Vertigo—Triamcinolone—atopic dermatitis	9.36e-05	0.000684	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	9.36e-05	0.000684	CcSEcCtD
Bromocriptine—Syncope—Triamcinolone—atopic dermatitis	9.35e-05	0.000683	CcSEcCtD
Bromocriptine—Vertigo—Methylprednisolone—atopic dermatitis	9.34e-05	0.000683	CcSEcCtD
Bromocriptine—Syncope—Methylprednisolone—atopic dermatitis	9.32e-05	0.000681	CcSEcCtD
Bromocriptine—Connective tissue disorder—Prednisone—atopic dermatitis	9.3e-05	0.000679	CcSEcCtD
Bromocriptine—Oedema—Prednisolone—atopic dermatitis	9.25e-05	0.000676	CcSEcCtD
Bromocriptine—Vomiting—Tacrolimus—atopic dermatitis	9.21e-05	0.000673	CcSEcCtD
Bromocriptine—Loss of consciousness—Triamcinolone—atopic dermatitis	9.16e-05	0.000669	CcSEcCtD
Bromocriptine—Loss of consciousness—Methylprednisolone—atopic dermatitis	9.14e-05	0.000668	CcSEcCtD
Bromocriptine—Rash—Tacrolimus—atopic dermatitis	9.13e-05	0.000667	CcSEcCtD
Bromocriptine—Dermatitis—Tacrolimus—atopic dermatitis	9.12e-05	0.000666	CcSEcCtD
Bromocriptine—Shock—Prednisolone—atopic dermatitis	9.1e-05	0.000665	CcSEcCtD
Bromocriptine—Headache—Tacrolimus—atopic dermatitis	9.07e-05	0.000663	CcSEcCtD
Bromocriptine—Oedema—Hydrocortisone—atopic dermatitis	9.03e-05	0.00066	CcSEcCtD
Bromocriptine—Convulsion—Triamcinolone—atopic dermatitis	9.03e-05	0.00066	CcSEcCtD
Bromocriptine—Tachycardia—Prednisolone—atopic dermatitis	9.03e-05	0.00066	CcSEcCtD
Bromocriptine—Convulsion—Methylprednisolone—atopic dermatitis	9.01e-05	0.000658	CcSEcCtD
Bromocriptine—Hypertension—Triamcinolone—atopic dermatitis	9e-05	0.000657	CcSEcCtD
Bromocriptine—Hypertension—Methylprednisolone—atopic dermatitis	8.98e-05	0.000656	CcSEcCtD
Bromocriptine—Infection—Hydrocortisone—atopic dermatitis	8.97e-05	0.000656	CcSEcCtD
Bromocriptine—Shock—Hydrocortisone—atopic dermatitis	8.89e-05	0.000649	CcSEcCtD
Bromocriptine—Nervous system disorder—Hydrocortisone—atopic dermatitis	8.86e-05	0.000647	CcSEcCtD
Bromocriptine—Eye disorder—Prednisone—atopic dermatitis	8.84e-05	0.000646	CcSEcCtD
Bromocriptine—Anxiety—Methylprednisolone—atopic dermatitis	8.82e-05	0.000645	CcSEcCtD
Bromocriptine—Tachycardia—Hydrocortisone—atopic dermatitis	8.82e-05	0.000644	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	8.79e-05	0.000642	CcSEcCtD
Bromocriptine—Skin disorder—Hydrocortisone—atopic dermatitis	8.77e-05	0.000641	CcSEcCtD
Bromocriptine—Dry mouth—Triamcinolone—atopic dermatitis	8.68e-05	0.000634	CcSEcCtD
Bromocriptine—Anorexia—Hydrocortisone—atopic dermatitis	8.61e-05	0.000629	CcSEcCtD
Bromocriptine—Nausea—Tacrolimus—atopic dermatitis	8.6e-05	0.000628	CcSEcCtD
Bromocriptine—Angiopathy—Prednisone—atopic dermatitis	8.58e-05	0.000627	CcSEcCtD
Bromocriptine—Confusional state—Methylprednisolone—atopic dermatitis	8.56e-05	0.000625	CcSEcCtD
Bromocriptine—Oedema—Triamcinolone—atopic dermatitis	8.51e-05	0.000621	CcSEcCtD
Bromocriptine—Vertigo—Betamethasone—atopic dermatitis	8.5e-05	0.000621	CcSEcCtD
Bromocriptine—Vertigo—Dexamethasone—atopic dermatitis	8.5e-05	0.000621	CcSEcCtD
Bromocriptine—Syncope—Betamethasone—atopic dermatitis	8.48e-05	0.00062	CcSEcCtD
Bromocriptine—Syncope—Dexamethasone—atopic dermatitis	8.48e-05	0.00062	CcSEcCtD
Bromocriptine—Arrhythmia—Prednisone—atopic dermatitis	8.45e-05	0.000617	CcSEcCtD
Bromocriptine—Infection—Triamcinolone—atopic dermatitis	8.45e-05	0.000617	CcSEcCtD
Bromocriptine—Hypotension—Hydrocortisone—atopic dermatitis	8.44e-05	0.000617	CcSEcCtD
Bromocriptine—Infection—Methylprednisolone—atopic dermatitis	8.43e-05	0.000616	CcSEcCtD
Bromocriptine—Shock—Triamcinolone—atopic dermatitis	8.37e-05	0.000611	CcSEcCtD
Bromocriptine—Insomnia—Prednisolone—atopic dermatitis	8.36e-05	0.000611	CcSEcCtD
Bromocriptine—Alopecia—Prednisone—atopic dermatitis	8.36e-05	0.000611	CcSEcCtD
Bromocriptine—Shock—Methylprednisolone—atopic dermatitis	8.35e-05	0.00061	CcSEcCtD
Bromocriptine—Nervous system disorder—Methylprednisolone—atopic dermatitis	8.32e-05	0.000608	CcSEcCtD
Bromocriptine—Loss of consciousness—Betamethasone—atopic dermatitis	8.31e-05	0.000607	CcSEcCtD
Bromocriptine—Loss of consciousness—Dexamethasone—atopic dermatitis	8.31e-05	0.000607	CcSEcCtD
Bromocriptine—Paraesthesia—Prednisolone—atopic dermatitis	8.3e-05	0.000607	CcSEcCtD
Bromocriptine—Tachycardia—Triamcinolone—atopic dermatitis	8.3e-05	0.000607	CcSEcCtD
Bromocriptine—Mental disorder—Prednisone—atopic dermatitis	8.29e-05	0.000606	CcSEcCtD
Bromocriptine—Tachycardia—Methylprednisolone—atopic dermatitis	8.28e-05	0.000605	CcSEcCtD
Bromocriptine—Skin disorder—Methylprednisolone—atopic dermatitis	8.24e-05	0.000602	CcSEcCtD
Bromocriptine—Convulsion—Betamethasone—atopic dermatitis	8.19e-05	0.000599	CcSEcCtD
Bromocriptine—Convulsion—Dexamethasone—atopic dermatitis	8.19e-05	0.000599	CcSEcCtD
Bromocriptine—Insomnia—Hydrocortisone—atopic dermatitis	8.17e-05	0.000597	CcSEcCtD
Bromocriptine—Hypertension—Betamethasone—atopic dermatitis	8.16e-05	0.000597	CcSEcCtD
Bromocriptine—Hypertension—Dexamethasone—atopic dermatitis	8.16e-05	0.000597	CcSEcCtD
Bromocriptine—Paraesthesia—Hydrocortisone—atopic dermatitis	8.11e-05	0.000593	CcSEcCtD
Bromocriptine—Anxiety—Betamethasone—atopic dermatitis	8.02e-05	0.000586	CcSEcCtD
Bromocriptine—Anxiety—Dexamethasone—atopic dermatitis	8.02e-05	0.000586	CcSEcCtD
Bromocriptine—Dyspepsia—Hydrocortisone—atopic dermatitis	7.95e-05	0.000581	CcSEcCtD
Bromocriptine—Hypotension—Methylprednisolone—atopic dermatitis	7.93e-05	0.000579	CcSEcCtD
Bromocriptine—Decreased appetite—Hydrocortisone—atopic dermatitis	7.85e-05	0.000574	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	7.8e-05	0.00057	CcSEcCtD
Bromocriptine—Fatigue—Hydrocortisone—atopic dermatitis	7.79e-05	0.000569	CcSEcCtD
Bromocriptine—Vision blurred—Prednisone—atopic dermatitis	7.76e-05	0.000567	CcSEcCtD
Bromocriptine—Oedema—Betamethasone—atopic dermatitis	7.72e-05	0.000564	CcSEcCtD
Bromocriptine—Oedema—Dexamethasone—atopic dermatitis	7.72e-05	0.000564	CcSEcCtD
Bromocriptine—Insomnia—Triamcinolone—atopic dermatitis	7.69e-05	0.000562	CcSEcCtD
Bromocriptine—Insomnia—Methylprednisolone—atopic dermatitis	7.68e-05	0.000561	CcSEcCtD
Bromocriptine—Infection—Dexamethasone—atopic dermatitis	7.67e-05	0.00056	CcSEcCtD
Bromocriptine—Infection—Betamethasone—atopic dermatitis	7.67e-05	0.00056	CcSEcCtD
Bromocriptine—Paraesthesia—Triamcinolone—atopic dermatitis	7.64e-05	0.000558	CcSEcCtD
Bromocriptine—Feeling abnormal—Prednisolone—atopic dermatitis	7.62e-05	0.000557	CcSEcCtD
Bromocriptine—Paraesthesia—Methylprednisolone—atopic dermatitis	7.62e-05	0.000557	CcSEcCtD
Bromocriptine—Shock—Betamethasone—atopic dermatitis	7.59e-05	0.000555	CcSEcCtD
Bromocriptine—Shock—Dexamethasone—atopic dermatitis	7.59e-05	0.000555	CcSEcCtD
Bromocriptine—Dyspnoea—Triamcinolone—atopic dermatitis	7.58e-05	0.000554	CcSEcCtD
Bromocriptine—Nervous system disorder—Betamethasone—atopic dermatitis	7.57e-05	0.000553	CcSEcCtD
Bromocriptine—Nervous system disorder—Dexamethasone—atopic dermatitis	7.57e-05	0.000553	CcSEcCtD
Bromocriptine—Agitation—Prednisone—atopic dermatitis	7.57e-05	0.000553	CcSEcCtD
Bromocriptine—Tachycardia—Betamethasone—atopic dermatitis	7.53e-05	0.00055	CcSEcCtD
Bromocriptine—Tachycardia—Dexamethasone—atopic dermatitis	7.53e-05	0.00055	CcSEcCtD
Bromocriptine—Dyspepsia—Triamcinolone—atopic dermatitis	7.49e-05	0.000547	CcSEcCtD
Bromocriptine—Dyspepsia—Methylprednisolone—atopic dermatitis	7.47e-05	0.000546	CcSEcCtD
Bromocriptine—Feeling abnormal—Hydrocortisone—atopic dermatitis	7.44e-05	0.000544	CcSEcCtD
Bromocriptine—Vertigo—Prednisone—atopic dermatitis	7.4e-05	0.000541	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	7.39e-05	0.00054	CcSEcCtD
Bromocriptine—Syncope—Prednisone—atopic dermatitis	7.38e-05	0.00054	CcSEcCtD
Bromocriptine—Anorexia—Dexamethasone—atopic dermatitis	7.36e-05	0.000538	CcSEcCtD
Bromocriptine—Anorexia—Betamethasone—atopic dermatitis	7.36e-05	0.000538	CcSEcCtD
Bromocriptine—Urticaria—Prednisolone—atopic dermatitis	7.35e-05	0.000537	CcSEcCtD
Bromocriptine—Fatigue—Triamcinolone—atopic dermatitis	7.33e-05	0.000536	CcSEcCtD
Bromocriptine—Fatigue—Methylprednisolone—atopic dermatitis	7.32e-05	0.000535	CcSEcCtD
Bromocriptine—Loss of consciousness—Prednisone—atopic dermatitis	7.24e-05	0.000529	CcSEcCtD
Bromocriptine—Hypotension—Dexamethasone—atopic dermatitis	7.21e-05	0.000527	CcSEcCtD
Bromocriptine—Hypotension—Betamethasone—atopic dermatitis	7.21e-05	0.000527	CcSEcCtD
Bromocriptine—Urticaria—Hydrocortisone—atopic dermatitis	7.18e-05	0.000524	CcSEcCtD
Bromocriptine—Body temperature increased—Hydrocortisone—atopic dermatitis	7.14e-05	0.000522	CcSEcCtD
Bromocriptine—Abdominal pain—Hydrocortisone—atopic dermatitis	7.14e-05	0.000522	CcSEcCtD
Bromocriptine—Convulsion—Prednisone—atopic dermatitis	7.13e-05	0.000521	CcSEcCtD
Bromocriptine—Hypertension—Prednisone—atopic dermatitis	7.11e-05	0.000519	CcSEcCtD
Bromocriptine—Feeling abnormal—Triamcinolone—atopic dermatitis	7.01e-05	0.000512	CcSEcCtD
Bromocriptine—Feeling abnormal—Methylprednisolone—atopic dermatitis	6.99e-05	0.000511	CcSEcCtD
Bromocriptine—Anxiety—Prednisone—atopic dermatitis	6.99e-05	0.00051	CcSEcCtD
Bromocriptine—Insomnia—Betamethasone—atopic dermatitis	6.98e-05	0.00051	CcSEcCtD
Bromocriptine—Insomnia—Dexamethasone—atopic dermatitis	6.98e-05	0.00051	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	6.96e-05	0.000509	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	6.94e-05	0.000507	CcSEcCtD
Bromocriptine—Paraesthesia—Dexamethasone—atopic dermatitis	6.93e-05	0.000506	CcSEcCtD
Bromocriptine—Paraesthesia—Betamethasone—atopic dermatitis	6.93e-05	0.000506	CcSEcCtD
Bromocriptine—Dyspepsia—Betamethasone—atopic dermatitis	6.79e-05	0.000496	CcSEcCtD
Bromocriptine—Dyspepsia—Dexamethasone—atopic dermatitis	6.79e-05	0.000496	CcSEcCtD
Bromocriptine—Urticaria—Triamcinolone—atopic dermatitis	6.76e-05	0.000494	CcSEcCtD
Bromocriptine—Urticaria—Methylprednisolone—atopic dermatitis	6.74e-05	0.000493	CcSEcCtD
Bromocriptine—Body temperature increased—Triamcinolone—atopic dermatitis	6.72e-05	0.000491	CcSEcCtD
Bromocriptine—Oedema—Prednisone—atopic dermatitis	6.72e-05	0.000491	CcSEcCtD
Bromocriptine—Abdominal pain—Methylprednisolone—atopic dermatitis	6.71e-05	0.00049	CcSEcCtD
Bromocriptine—Decreased appetite—Dexamethasone—atopic dermatitis	6.71e-05	0.00049	CcSEcCtD
Bromocriptine—Decreased appetite—Betamethasone—atopic dermatitis	6.71e-05	0.00049	CcSEcCtD
Bromocriptine—Infection—Prednisone—atopic dermatitis	6.68e-05	0.000488	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	6.66e-05	0.000487	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Betamethasone—atopic dermatitis	6.66e-05	0.000487	CcSEcCtD
Bromocriptine—Fatigue—Dexamethasone—atopic dermatitis	6.65e-05	0.000486	CcSEcCtD
Bromocriptine—Fatigue—Betamethasone—atopic dermatitis	6.65e-05	0.000486	CcSEcCtD
Bromocriptine—Shock—Prednisone—atopic dermatitis	6.61e-05	0.000483	CcSEcCtD
Bromocriptine—Nervous system disorder—Prednisone—atopic dermatitis	6.59e-05	0.000482	CcSEcCtD
Bromocriptine—Tachycardia—Prednisone—atopic dermatitis	6.56e-05	0.000479	CcSEcCtD
Bromocriptine—Skin disorder—Prednisone—atopic dermatitis	6.53e-05	0.000477	CcSEcCtD
Bromocriptine—Asthenia—Hydrocortisone—atopic dermatitis	6.48e-05	0.000474	CcSEcCtD
Bromocriptine—Anorexia—Prednisone—atopic dermatitis	6.41e-05	0.000468	CcSEcCtD
Bromocriptine—Feeling abnormal—Betamethasone—atopic dermatitis	6.36e-05	0.000465	CcSEcCtD
Bromocriptine—Feeling abnormal—Dexamethasone—atopic dermatitis	6.36e-05	0.000465	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	6.31e-05	0.000461	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Betamethasone—atopic dermatitis	6.31e-05	0.000461	CcSEcCtD
Bromocriptine—Diarrhoea—Hydrocortisone—atopic dermatitis	6.18e-05	0.000452	CcSEcCtD
Bromocriptine—Urticaria—Dexamethasone—atopic dermatitis	6.13e-05	0.000448	CcSEcCtD
Bromocriptine—Urticaria—Betamethasone—atopic dermatitis	6.13e-05	0.000448	CcSEcCtD
Bromocriptine—Dizziness—Prednisolone—atopic dermatitis	6.12e-05	0.000447	CcSEcCtD
Bromocriptine—Asthenia—Triamcinolone—atopic dermatitis	6.1e-05	0.000446	CcSEcCtD
Bromocriptine—Abdominal pain—Betamethasone—atopic dermatitis	6.1e-05	0.000446	CcSEcCtD
Bromocriptine—Abdominal pain—Dexamethasone—atopic dermatitis	6.1e-05	0.000446	CcSEcCtD
Bromocriptine—Body temperature increased—Betamethasone—atopic dermatitis	6.1e-05	0.000446	CcSEcCtD
Bromocriptine—Body temperature increased—Dexamethasone—atopic dermatitis	6.1e-05	0.000446	CcSEcCtD
Bromocriptine—Asthenia—Methylprednisolone—atopic dermatitis	6.09e-05	0.000445	CcSEcCtD
Bromocriptine—Insomnia—Prednisone—atopic dermatitis	6.08e-05	0.000444	CcSEcCtD
Bromocriptine—Paraesthesia—Prednisone—atopic dermatitis	6.03e-05	0.000441	CcSEcCtD
Bromocriptine—Dizziness—Hydrocortisone—atopic dermatitis	5.97e-05	0.000436	CcSEcCtD
Bromocriptine—Dyspepsia—Prednisone—atopic dermatitis	5.92e-05	0.000432	CcSEcCtD
Bromocriptine—Decreased appetite—Prednisone—atopic dermatitis	5.84e-05	0.000427	CcSEcCtD
Bromocriptine—Rash—Prednisolone—atopic dermatitis	5.83e-05	0.000426	CcSEcCtD
Bromocriptine—Dermatitis—Prednisolone—atopic dermatitis	5.83e-05	0.000426	CcSEcCtD
Bromocriptine—Diarrhoea—Methylprednisolone—atopic dermatitis	5.81e-05	0.000424	CcSEcCtD
Bromocriptine—Fatigue—Prednisone—atopic dermatitis	5.79e-05	0.000423	CcSEcCtD
Bromocriptine—Headache—Prednisolone—atopic dermatitis	5.79e-05	0.000423	CcSEcCtD
Bromocriptine—Constipation—Prednisone—atopic dermatitis	5.75e-05	0.00042	CcSEcCtD
Bromocriptine—Vomiting—Hydrocortisone—atopic dermatitis	5.74e-05	0.00042	CcSEcCtD
Bromocriptine—Rash—Hydrocortisone—atopic dermatitis	5.7e-05	0.000416	CcSEcCtD
Bromocriptine—Dermatitis—Hydrocortisone—atopic dermatitis	5.69e-05	0.000416	CcSEcCtD
Bromocriptine—Headache—Hydrocortisone—atopic dermatitis	5.66e-05	0.000413	CcSEcCtD
Bromocriptine—Dizziness—Triamcinolone—atopic dermatitis	5.62e-05	0.000411	CcSEcCtD
Bromocriptine—Dizziness—Methylprednisolone—atopic dermatitis	5.61e-05	0.00041	CcSEcCtD
Bromocriptine—Feeling abnormal—Prednisone—atopic dermatitis	5.54e-05	0.000405	CcSEcCtD
Bromocriptine—Asthenia—Betamethasone—atopic dermatitis	5.54e-05	0.000405	CcSEcCtD
Bromocriptine—Asthenia—Dexamethasone—atopic dermatitis	5.54e-05	0.000405	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Prednisone—atopic dermatitis	5.5e-05	0.000402	CcSEcCtD
Bromocriptine—Nausea—Prednisolone—atopic dermatitis	5.49e-05	0.000401	CcSEcCtD
Bromocriptine—Vomiting—Triamcinolone—atopic dermatitis	5.41e-05	0.000395	CcSEcCtD
Bromocriptine—Vomiting—Methylprednisolone—atopic dermatitis	5.4e-05	0.000394	CcSEcCtD
Bromocriptine—Nausea—Hydrocortisone—atopic dermatitis	5.37e-05	0.000392	CcSEcCtD
Bromocriptine—Rash—Triamcinolone—atopic dermatitis	5.36e-05	0.000392	CcSEcCtD
Bromocriptine—Dermatitis—Triamcinolone—atopic dermatitis	5.36e-05	0.000391	CcSEcCtD
Bromocriptine—Rash—Methylprednisolone—atopic dermatitis	5.35e-05	0.000391	CcSEcCtD
Bromocriptine—Dermatitis—Methylprednisolone—atopic dermatitis	5.35e-05	0.000391	CcSEcCtD
Bromocriptine—Urticaria—Prednisone—atopic dermatitis	5.34e-05	0.00039	CcSEcCtD
Bromocriptine—Headache—Triamcinolone—atopic dermatitis	5.33e-05	0.000389	CcSEcCtD
Bromocriptine—Headache—Methylprednisolone—atopic dermatitis	5.32e-05	0.000388	CcSEcCtD
Bromocriptine—Abdominal pain—Prednisone—atopic dermatitis	5.31e-05	0.000388	CcSEcCtD
Bromocriptine—Body temperature increased—Prednisone—atopic dermatitis	5.31e-05	0.000388	CcSEcCtD
Bromocriptine—Diarrhoea—Dexamethasone—atopic dermatitis	5.28e-05	0.000386	CcSEcCtD
Bromocriptine—Diarrhoea—Betamethasone—atopic dermatitis	5.28e-05	0.000386	CcSEcCtD
Bromocriptine—Dizziness—Dexamethasone—atopic dermatitis	5.1e-05	0.000373	CcSEcCtD
Bromocriptine—Dizziness—Betamethasone—atopic dermatitis	5.1e-05	0.000373	CcSEcCtD
Bromocriptine—Nausea—Triamcinolone—atopic dermatitis	5.05e-05	0.000369	CcSEcCtD
Bromocriptine—Nausea—Methylprednisolone—atopic dermatitis	5.04e-05	0.000368	CcSEcCtD
Bromocriptine—Vomiting—Betamethasone—atopic dermatitis	4.91e-05	0.000359	CcSEcCtD
Bromocriptine—Vomiting—Dexamethasone—atopic dermatitis	4.91e-05	0.000359	CcSEcCtD
Bromocriptine—Rash—Dexamethasone—atopic dermatitis	4.87e-05	0.000356	CcSEcCtD
Bromocriptine—Rash—Betamethasone—atopic dermatitis	4.87e-05	0.000356	CcSEcCtD
Bromocriptine—Dermatitis—Dexamethasone—atopic dermatitis	4.86e-05	0.000355	CcSEcCtD
Bromocriptine—Dermatitis—Betamethasone—atopic dermatitis	4.86e-05	0.000355	CcSEcCtD
Bromocriptine—Headache—Dexamethasone—atopic dermatitis	4.83e-05	0.000353	CcSEcCtD
Bromocriptine—Headache—Betamethasone—atopic dermatitis	4.83e-05	0.000353	CcSEcCtD
Bromocriptine—Asthenia—Prednisone—atopic dermatitis	4.82e-05	0.000352	CcSEcCtD
Bromocriptine—Diarrhoea—Prednisone—atopic dermatitis	4.6e-05	0.000336	CcSEcCtD
Bromocriptine—Nausea—Betamethasone—atopic dermatitis	4.58e-05	0.000335	CcSEcCtD
Bromocriptine—Nausea—Dexamethasone—atopic dermatitis	4.58e-05	0.000335	CcSEcCtD
Bromocriptine—Dizziness—Prednisone—atopic dermatitis	4.44e-05	0.000325	CcSEcCtD
Bromocriptine—Vomiting—Prednisone—atopic dermatitis	4.27e-05	0.000312	CcSEcCtD
Bromocriptine—Rash—Prednisone—atopic dermatitis	4.24e-05	0.00031	CcSEcCtD
Bromocriptine—Dermatitis—Prednisone—atopic dermatitis	4.23e-05	0.000309	CcSEcCtD
Bromocriptine—Headache—Prednisone—atopic dermatitis	4.21e-05	0.000308	CcSEcCtD
Bromocriptine—Nausea—Prednisone—atopic dermatitis	3.99e-05	0.000292	CcSEcCtD
Bromocriptine—ADRA2B—Signaling Pathways—CXCL10—atopic dermatitis	9.83e-06	0.000155	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—CCR5—atopic dermatitis	9.79e-06	0.000155	CbGpPWpGaD
Bromocriptine—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	9.79e-06	0.000155	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR downstream signaling—IL2—atopic dermatitis	9.77e-06	0.000155	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—NGF—atopic dermatitis	9.77e-06	0.000154	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL5—atopic dermatitis	9.77e-06	0.000154	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—CXCL8—atopic dermatitis	9.73e-06	0.000154	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—IL2—atopic dermatitis	9.72e-06	0.000154	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—IL2—atopic dermatitis	9.71e-06	0.000154	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—CCR5—atopic dermatitis	9.66e-06	0.000153	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—IL2—atopic dermatitis	9.65e-06	0.000153	CbGpPWpGaD
Bromocriptine—DRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	9.64e-06	0.000152	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL5—atopic dermatitis	9.61e-06	0.000152	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR downstream signaling—CXCL8—atopic dermatitis	9.52e-06	0.00015	CbGpPWpGaD
Bromocriptine—DRD3—GPCR downstream signaling—CXCL8—atopic dermatitis	9.52e-06	0.00015	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—CCR5—atopic dermatitis	9.51e-06	0.00015	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CCL5—atopic dermatitis	9.5e-06	0.00015	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CXCL10—atopic dermatitis	9.49e-06	0.00015	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—IL2—atopic dermatitis	9.45e-06	0.000149	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CXCL10—atopic dermatitis	9.44e-06	0.000149	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL5—atopic dermatitis	9.41e-06	0.000149	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TAC1—atopic dermatitis	9.41e-06	0.000149	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—NPS—atopic dermatitis	9.41e-06	0.000149	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CCL5—atopic dermatitis	9.37e-06	0.000148	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CCL5—atopic dermatitis	9.37e-06	0.000148	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—NGF—atopic dermatitis	9.33e-06	0.000147	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—IL2—atopic dermatitis	9.3e-06	0.000147	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—CXCL8—atopic dermatitis	9.29e-06	0.000147	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CXCR3—atopic dermatitis	9.23e-06	0.000146	CbGpPWpGaD
Bromocriptine—DRD1—GPCR downstream signaling—IL2—atopic dermatitis	9.22e-06	0.000146	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CXCL10—atopic dermatitis	9.18e-06	0.000145	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR downstream signaling—IL2—atopic dermatitis	9.09e-06	0.000144	CbGpPWpGaD
Bromocriptine—DRD3—GPCR downstream signaling—IL2—atopic dermatitis	9.09e-06	0.000144	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—CCR5—atopic dermatitis	9.07e-06	0.000143	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CXCL10—atopic dermatitis	9.04e-06	0.000143	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—IL2—atopic dermatitis	8.88e-06	0.00014	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—NGF—atopic dermatitis	8.8e-06	0.000139	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—CXCL8—atopic dermatitis	8.76e-06	0.000138	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL5—atopic dermatitis	8.75e-06	0.000138	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GLB1—atopic dermatitis	8.71e-06	0.000138	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—NGF—atopic dermatitis	8.68e-06	0.000137	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—NGF—atopic dermatitis	8.68e-06	0.000137	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR downstream signaling—CXCL8—atopic dermatitis	8.67e-06	0.000137	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—CXCL8—atopic dermatitis	8.64e-06	0.000137	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—CXCL8—atopic dermatitis	8.64e-06	0.000137	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—CXCL8—atopic dermatitis	8.59e-06	0.000136	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CCR5—atopic dermatitis	8.56e-06	0.000135	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CCL5—atopic dermatitis	8.54e-06	0.000135	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CCL5—atopic dermatitis	8.46e-06	0.000134	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CCR5—atopic dermatitis	8.44e-06	0.000133	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CCR5—atopic dermatitis	8.44e-06	0.000133	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—NFKBIA—atopic dermatitis	8.43e-06	0.000133	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—NFKBIA—atopic dermatitis	8.42e-06	0.000133	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—IL2—atopic dermatitis	8.37e-06	0.000132	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—NFKBIA—atopic dermatitis	8.36e-06	0.000132	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ADSL—atopic dermatitis	8.35e-06	0.000132	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CXCL10—atopic dermatitis	8.33e-06	0.000132	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	8.29e-06	0.000131	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR downstream signaling—IL2—atopic dermatitis	8.29e-06	0.000131	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—IL2—atopic dermatitis	8.26e-06	0.000131	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—IL2—atopic dermatitis	8.26e-06	0.000131	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—CXCL8—atopic dermatitis	8.25e-06	0.00013	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	8.22e-06	0.00013	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—IL2—atopic dermatitis	8.21e-06	0.00013	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CXCL10—atopic dermatitis	8.2e-06	0.00013	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—NFKBIA—atopic dermatitis	8.19e-06	0.000129	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	8.17e-06	0.000129	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—PPARA—atopic dermatitis	8.16e-06	0.000129	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CCL5—atopic dermatitis	8.13e-06	0.000128	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—NFKBIA—atopic dermatitis	8.06e-06	0.000127	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CXCL10—atopic dermatitis	8.03e-06	0.000127	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—CXCL8—atopic dermatitis	8.03e-06	0.000127	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	7.93e-06	0.000125	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—NGF—atopic dermatitis	7.91e-06	0.000125	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CCL5—atopic dermatitis	7.9e-06	0.000125	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—CXCL8—atopic dermatitis	7.9e-06	0.000125	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—IL2—atopic dermatitis	7.89e-06	0.000125	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—CXCL8—atopic dermatitis	7.87e-06	0.000124	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—NGF—atopic dermatitis	7.84e-06	0.000124	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—CXCL8—atopic dermatitis	7.8e-06	0.000123	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—CXCL8—atopic dermatitis	7.79e-06	0.000123	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CCL5—atopic dermatitis	7.78e-06	0.000123	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CCR5—atopic dermatitis	7.69e-06	0.000122	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—NFKBIA—atopic dermatitis	7.69e-06	0.000122	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—IL2—atopic dermatitis	7.67e-06	0.000121	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CCR5—atopic dermatitis	7.62e-06	0.000121	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—NGF—atopic dermatitis	7.57e-06	0.00012	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—IL2—atopic dermatitis	7.55e-06	0.000119	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	7.53e-06	0.000119	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—NGF—atopic dermatitis	7.53e-06	0.000119	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—IL2—atopic dermatitis	7.53e-06	0.000119	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—CXCL8—atopic dermatitis	7.49e-06	0.000118	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CXCL10—atopic dermatitis	7.46e-06	0.000118	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—IL2—atopic dermatitis	7.46e-06	0.000118	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—IL2—atopic dermatitis	7.44e-06	0.000118	CbGpPWpGaD
Bromocriptine—DRD5—Signaling by GPCR—IL6—atopic dermatitis	7.4e-06	0.000117	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	7.36e-06	0.000116	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CCR5—atopic dermatitis	7.32e-06	0.000116	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—NGF—atopic dermatitis	7.32e-06	0.000116	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—CXCL8—atopic dermatitis	7.29e-06	0.000115	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—CXCL8—atopic dermatitis	7.28e-06	0.000115	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—NFKBIA—atopic dermatitis	7.26e-06	0.000115	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—NGF—atopic dermatitis	7.2e-06	0.000114	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	7.2e-06	0.000114	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—CXCL8—atopic dermatitis	7.17e-06	0.000113	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CCL5—atopic dermatitis	7.17e-06	0.000113	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—CXCL8—atopic dermatitis	7.17e-06	0.000113	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—IL2—atopic dermatitis	7.16e-06	0.000113	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—NFKBIA—atopic dermatitis	7.16e-06	0.000113	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—NFKBIA—atopic dermatitis	7.16e-06	0.000113	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CCR5—atopic dermatitis	7.12e-06	0.000113	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CCL5—atopic dermatitis	7.06e-06	0.000112	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—CXCL8—atopic dermatitis	7.02e-06	0.000111	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CCR5—atopic dermatitis	7.01e-06	0.000111	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—IL2—atopic dermatitis	6.96e-06	0.00011	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—IL2—atopic dermatitis	6.96e-06	0.00011	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CCL5—atopic dermatitis	6.91e-06	0.000109	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—IL2—atopic dermatitis	6.85e-06	0.000108	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—MAPK8—atopic dermatitis	6.85e-06	0.000108	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—IL2—atopic dermatitis	6.85e-06	0.000108	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—IL2—atopic dermatitis	6.7e-06	0.000106	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—NGF—atopic dermatitis	6.64e-06	0.000105	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PPARA—atopic dermatitis	6.63e-06	0.000105	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—CXCL8—atopic dermatitis	6.61e-06	0.000105	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—NGF—atopic dermatitis	6.54e-06	0.000103	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—NFKBIA—atopic dermatitis	6.52e-06	0.000103	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	6.52e-06	0.000103	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—CXCL8—atopic dermatitis	6.51e-06	0.000103	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—NFKBIA—atopic dermatitis	6.46e-06	0.000102	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CCR5—atopic dermatitis	6.46e-06	0.000102	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CCL5—atopic dermatitis	6.42e-06	0.000101	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—NGF—atopic dermatitis	6.4e-06	0.000101	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—CXCL8—atopic dermatitis	6.37e-06	0.000101	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CCR5—atopic dermatitis	6.36e-06	0.000101	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—IL2—atopic dermatitis	6.32e-06	9.99e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	6.24e-06	9.86e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—IL2—atopic dermatitis	6.23e-06	9.85e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CCR5—atopic dermatitis	6.23e-06	9.84e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—IL2—atopic dermatitis	6.22e-06	9.83e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—NFKBIA—atopic dermatitis	6.21e-06	9.81e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—IL2—atopic dermatitis	6.09e-06	9.63e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—NFKBIA—atopic dermatitis	6.04e-06	9.54e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—CXCL8—atopic dermatitis	6.01e-06	9.5e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—CXCL8—atopic dermatitis	6e-06	9.49e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—CXCL8—atopic dermatitis	5.96e-06	9.43e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—NGF—atopic dermatitis	5.95e-06	9.4e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—NFKBIA—atopic dermatitis	5.94e-06	9.39e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—CXCL8—atopic dermatitis	5.92e-06	9.36e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—CXCL8—atopic dermatitis	5.84e-06	9.23e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CCR5—atopic dermatitis	5.78e-06	9.14e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—CXCL8—atopic dermatitis	5.75e-06	9.09e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—IL2—atopic dermatitis	5.74e-06	9.08e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—IL2—atopic dermatitis	5.74e-06	9.07e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—IL6—atopic dermatitis	5.72e-06	9.04e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—IL6—atopic dermatitis	5.71e-06	9.03e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—IL2—atopic dermatitis	5.7e-06	9.01e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—IL6—atopic dermatitis	5.67e-06	8.97e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—IL2—atopic dermatitis	5.66e-06	8.94e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IL2—atopic dermatitis	5.58e-06	8.82e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—IL6—atopic dermatitis	5.55e-06	8.78e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IL2—atopic dermatitis	5.49e-06	8.68e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—CXCL8—atopic dermatitis	5.49e-06	8.67e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—NFKBIA—atopic dermatitis	5.48e-06	8.66e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—IL6—atopic dermatitis	5.47e-06	8.64e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—NFKBIA—atopic dermatitis	5.39e-06	8.52e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—MAPK8—atopic dermatitis	5.29e-06	8.36e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—MAPK8—atopic dermatitis	5.28e-06	8.35e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—NFKBIA—atopic dermatitis	5.28e-06	8.34e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—MAPK8—atopic dermatitis	5.25e-06	8.29e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IL2—atopic dermatitis	5.24e-06	8.29e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—IL6—atopic dermatitis	5.22e-06	8.25e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CXCL8—atopic dermatitis	5.17e-06	8.18e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—MAPK8—atopic dermatitis	5.14e-06	8.12e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CXCL8—atopic dermatitis	5.11e-06	8.07e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CXCL8—atopic dermatitis	5.11e-06	8.07e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—MAPK8—atopic dermatitis	5.06e-06	7.99e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IL2—atopic dermatitis	4.94e-06	7.82e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—IL6—atopic dermatitis	4.92e-06	7.78e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—NFKBIA—atopic dermatitis	4.9e-06	7.75e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IL2—atopic dermatitis	4.88e-06	7.71e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IL2—atopic dermatitis	4.88e-06	7.71e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—IL6—atopic dermatitis	4.85e-06	7.67e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—IL6—atopic dermatitis	4.85e-06	7.67e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—MAPK8—atopic dermatitis	4.83e-06	7.63e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CXCL8—atopic dermatitis	4.65e-06	7.35e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CXCL8—atopic dermatitis	4.61e-06	7.29e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PPARA—atopic dermatitis	4.59e-06	7.25e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MAPK8—atopic dermatitis	4.55e-06	7.19e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MAPK8—atopic dermatitis	4.49e-06	7.1e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MAPK8—atopic dermatitis	4.49e-06	7.1e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	4.45e-06	7.03e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL2—atopic dermatitis	4.45e-06	7.03e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CXCL8—atopic dermatitis	4.43e-06	7e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—IL6—atopic dermatitis	4.42e-06	6.99e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL2—atopic dermatitis	4.4e-06	6.96e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—IL6—atopic dermatitis	4.38e-06	6.93e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—IL6—atopic dermatitis	4.37e-06	6.91e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CXCL8—atopic dermatitis	4.31e-06	6.81e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL2—atopic dermatitis	4.25e-06	6.72e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CXCL8—atopic dermatitis	4.24e-06	6.7e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	4.23e-06	6.69e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL2—atopic dermatitis	4.23e-06	6.69e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—IL6—atopic dermatitis	4.21e-06	6.65e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL2—atopic dermatitis	4.11e-06	6.5e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—IL6—atopic dermatitis	4.09e-06	6.47e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MAPK8—atopic dermatitis	4.09e-06	6.47e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MAPK8—atopic dermatitis	4.05e-06	6.41e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL2—atopic dermatitis	4.05e-06	6.4e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—IL6—atopic dermatitis	4.03e-06	6.37e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	3.91e-06	6.19e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CXCL8—atopic dermatitis	3.91e-06	6.18e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MAPK8—atopic dermatitis	3.89e-06	6.16e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CXCL8—atopic dermatitis	3.84e-06	6.08e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MAPK8—atopic dermatitis	3.79e-06	5.99e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CXCL8—atopic dermatitis	3.76e-06	5.95e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL2—atopic dermatitis	3.73e-06	5.9e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MAPK8—atopic dermatitis	3.73e-06	5.89e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—IL6—atopic dermatitis	3.71e-06	5.87e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL2—atopic dermatitis	3.67e-06	5.81e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PPARA—atopic dermatitis	3.66e-06	5.79e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—IL6—atopic dermatitis	3.66e-06	5.78e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL2—atopic dermatitis	3.6e-06	5.69e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—IL6—atopic dermatitis	3.58e-06	5.66e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CXCL8—atopic dermatitis	3.5e-06	5.53e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MAPK8—atopic dermatitis	3.44e-06	5.43e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MAPK8—atopic dermatitis	3.38e-06	5.34e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—IL6—atopic dermatitis	3.38e-06	5.34e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—IL6—atopic dermatitis	3.37e-06	5.33e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—IL6—atopic dermatitis	3.35e-06	5.3e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL2—atopic dermatitis	3.34e-06	5.28e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—IL6—atopic dermatitis	3.33e-06	5.26e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MAPK8—atopic dermatitis	3.31e-06	5.23e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IL6—atopic dermatitis	3.28e-06	5.19e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IL6—atopic dermatitis	3.23e-06	5.1e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IL6—atopic dermatitis	3.08e-06	4.87e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MAPK8—atopic dermatitis	3.08e-06	4.86e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IL6—atopic dermatitis	2.91e-06	4.59e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IL6—atopic dermatitis	2.87e-06	4.53e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IL6—atopic dermatitis	2.87e-06	4.53e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PPARA—atopic dermatitis	2.83e-06	4.47e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL6—atopic dermatitis	2.61e-06	4.13e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL6—atopic dermatitis	2.59e-06	4.09e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL6—atopic dermatitis	2.5e-06	3.95e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL6—atopic dermatitis	2.49e-06	3.93e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL6—atopic dermatitis	2.42e-06	3.82e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL6—atopic dermatitis	2.38e-06	3.76e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL6—atopic dermatitis	2.19e-06	3.47e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL6—atopic dermatitis	2.16e-06	3.41e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL6—atopic dermatitis	2.11e-06	3.34e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL6—atopic dermatitis	1.96e-06	3.11e-05	CbGpPWpGaD
